Genotyping Detection of Human Papillomavirus in Benign Prostate Hyperplasia in Ramadi City
DOI:
https://doi.org/10.52783/jns.v14.1880Keywords:
HPV-16, HPV-18, prostate cancer, benign prostatic hyperplasiaAbstract
Background: The presence of Human Papillomavirus (HPV) in Benign Prostate Hyperplasia (BPH) could suggest an important role of viral infection in the pathogenesis of BPH, potentially influencing treatment strategies. If a correlation is established, it could lead to increased awareness and screening for HPV in male populations, similar to cervical cancer screening in women.
Objectives: To detect HPV serotypes in patients with BPH and to disclose their potential roles in the pathophysiology of BPH.
Patients and methods: A case control study, involve collection of 75 specimens from male individuals with BPH and compared to 75 specimens from age-matched healthy male volunteers. The samples were processed at College of Medicine laboratories- University of Anbar and Private Specialized laboratories in Ramadi city from the period December 2023 to April 2024, patient samples were collected based on physicians' recommendations, suspecting a viral infection with human Papillomavirus. In both groups, a quantitative test was conducted for specific HPV IgM16 and HPV IgM18 in serum using an Enzyme Linked Immunosorbant Assay (ELISA), Genotyping of HPV in the urine were detected by conventional PCR technique.
Results: The statistic results indicated that the mean value of specific HPV16 IgM-is 11.02±0.968 compared to control group value 0.647±0.132 at significant differences P= 0.0001, while mean value of –specific HPV18 IgM is 0.752±0.235 compared to control group value 0.165±0.015 at significant differences P=0.019. The molecular screening results indicated that the HPV16 serotype is most frequent in patients with BPH than HPV18, (78.7%) compared (20%)respectively.
Conclusion: HPVs, mainly serotype 16 and 18 were detected in patients with BPH, the study also shows human immune response to HPV 16 and HPV 18 in men with BPH which provide valuable information about immune state, understand how BPH develop, find new ways for diagnoses and development of BPH treatments. Urine sampling appears to be a suitable surrogate sample for DNA HPV serotype testing in male with limited access to healthcare.
Downloads
Metrics
References
A. Uberoi and P. F. Lambert, “Rodent Papillomaviruses.,” Viruses, vol. 9, no. 12, Nov. 2017, doi: 10.3390/v9120362.
E. Jeannot et al., “Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among Undergraduate Men and Women Healthcare University Students in Switzerland.,” Vaccines, vol. 7, no. 4, Sep. 2019, doi: 10.3390/vaccines7040130.
E. M. Burd, “Human papillomavirus and cervical cancer.,” Clin. Microbiol. Rev., vol. 16, no. 1, pp. 1–17, Jan. 2003, doi: 10.1128/CMR.16.1.1-17.2003.
H. G. Ahmed et al., “Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer.,” Asian Pac. J. Cancer Prev., vol. 18, no. 6, pp. 1543–1548, Jun. 2017, doi: 10.22034/APJCP.2017.18.6.1543.
R. Unnikrishnan, N. Almassi, and K. Fareed, “Benign prostatic hyperplasia: Evaluation and medical management in primary care,” Cleve. Clin. J. Med., vol. 84, no. 1, pp. 53–64, 2017, doi: 10.3949/ccjm.84a.16008.
N. Dakroury and C. Bachtsetzis, “Can Benign Prostatic Hyperplasia Be A Prostate Cancer? A Narrative Review,” Int. J. Med. Rev. Case Reports, vol. 5, no. 0, p. 1, 2020, doi: 10.5455/ijmrcr.benign-prostatic-hyperplasia-cancer.
M. Ng, S. W. Leslie, and K. M. Baradhi, “Benign Prostatic Hyperplasia.,” Treasure Island (FL), 2024.
C. G. Roehrborn, “Benign prostatic hyperplasia: an overview.,” Rev. Urol., vol. 7 Suppl 9, no. Suppl 9, pp. S3–S14, 2005.
E. D. Yeboah and A. W. Hsing, “BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.,” J. West African Coll. Surg., vol. 6, no. 4, pp. x–xviii, 2016.
M. Y. Ahmed et al., “Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population.,” Sci. Rep., vol. 13, no. 1, p. 7633, May 2023, doi: 10.1038/s41598-023-34734-3.
Tsydenova, I. A., Ibragimova, M. K., Tsyganov, M. M., & Litviakov, N. V. (2023) Human papillomavirus and prostate cancer: Systematic review and meta-analysis. Scientific Reports 13(1);1-8. doi:10.1038/s41598-023-43767-7
A. Vorsters, I. Micalessi, J. Bilcke, M. Ieven, J. Bogers, and P. Van Damme, “Detection of human papillomavirus DNA in urine. A review of the literature.,” Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., vol. 31, no. 5, pp. 627–640, May 2012, doi: 10.1007/s10096-011-1358-z.
I. A. Tsydenova, M. K. Ibragimova, M. M. Tsyganov, and N. V Litviakov, “Human papillomavirus and prostate cancer: systematic review and meta-analysis.,” Sci. Rep., vol. 13, no. 1, p. 16597, Oct. 2023, doi: 10.1038/s41598-023-43767-7.
C. N. Miller et al., “Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine.,” Vaccine, vol. 39, no. 37, pp. 5295–5301, Aug. 2021, doi: 10.1016/j.vaccine.2021.07.069.
L. Chihu-Amparan, A. Pedroza-Saavedra, and L. Gutierrez-Xicotencatl, “The Immune Response Generated against HPV Infection in Men and Its Implications in the Diagnosis of Cancer.,” Microorganisms, vol. 11, no. 6, Jun. 2023, doi: 10.3390/microorganisms11061609.
A. Bordigoni, A. Motte, H. Tissot-Dupont, P. Colson, and C. Desnues, “Development and validation of a multiplex qPCR assay for detection and relative quantification of HPV16 and HPV18 E6 and E7 oncogenes.,” Sci. Rep., vol. 11, no. 1, p. 4039, Feb. 2021, doi: 10.1038/s41598-021-83489-2.
M. Hisada, C. S. Rabkin, H. D. Strickler, W. E. Wright, R. E. Christianson, and B. J. van den Berg, “Human papillomavirus antibody and risk of prostate cancer.,” JAMA, vol. 283, no. 3. United States, pp. 340–341, Jan. 2000. doi: 10.1001/jama.283.3.340-a.
P. J. McNicol and J. G. Dodd, “Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay.,” J. Clin. Microbiol., vol. 28, no. 3, pp. 409–412, Mar. 1990, doi: 10.1128/jcm.28.3.409-412.1990.
R. Opeyemi Bello et al., “Does Human Papillomavirus Play a Causative Role in Prostate Cancer? A Systematic Review Using Bradford Hill’s Criteria.,” Cancers (Basel)., vol. 15, no. 15, Jul. 2023, doi: 10.3390/cancers15153897.
Hazaa, A. A., & Nafea, H. H. (2023, December). Response of Broiler to Addition Dimethylglycine of Normal and Low-Energy Diets in Productive Performance. In IOP Conference Series: Earth and Environmental Science (Vol. 1262, No. 7, p. 072073). IOP Publishing.
Quintanilla-Villanueva, G. E., Rodríguez-Delgado, M. M., Villarreal-Chiu, J. F., Blanco-Gámez, E. A., & Luna-Moreno, D. (2024). The role of amino acid glycine on cardiovascular health and its beneficial effects: a narrative review. Journal of Vascular Diseases, 3(2), 201-211.
Hind Q. Jameel Al Ani, Noor N. AlHayani and Raid M. Al Ani, “Efficacy of the estimation of saliva sample by reverse transcriptase polymerase chain reaction in detection of SARS cov 2 in Gallujah city Iraq, JPAM., 2022, 16(4), 2416-2424.
Al-Hayani, N. N., Mohaisen, M. R., & Rashid, S. A. (2024). Deep learning-assisted design of de novo protein binders targeting hepatitis C virus E2 protein. Matematicheskaya Biologiya i Bioinformatika, 19(2), 402-417.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
